ArticleOncotarget2018

Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma.

Xuran Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.